Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | None | 0.979 | 2327 | 632 | 1989 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | strong | 0.965 | 141 | 205 | 1992 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.100 | None | 0.946 | 112 | 14 | 1991 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | None | 0.936 | 47 | 7 | 1998 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | None | 1.000 | 47 | 4 | 1998 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
phenotype | 0.100 | None | 1.000 | 38 | 4 | 1995 | 2017 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
phenotype | 0.500 | None | 1.000 | 33 | 0 | 1995 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 25 | 16 | 1991 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 24 | 0 | 1995 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.390 | None | 1.000 | 24 | 0 | 1991 | 2017 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 23 | 4 | 2001 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.100 | None | 1.000 | 23 | 0 | 1997 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.100 | None | 1.000 | 21 | 18 | 1991 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | strong | 0.952 | 21 | 3 | 1995 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 20 | 4 | 1998 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.330 | None | 1.000 | 18 | 0 | 1991 | 2018 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.100 | None | 1.000 | 18 | 1 | 1992 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.100 | None | 1.000 | 17 | 1 | 1998 | 2016 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 0.938 | 16 | 6 | 1999 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.100 | None | 1.000 | 16 | 4 | 1998 | 2015 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 0.933 | 15 | 3 | 2004 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 2012 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.500 | None | 1.000 | 14 | 0 | 1996 | 2019 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1998 | 2018 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1996 | 2019 |